A股異動 | 振德醫療(603301.SH)跌逾8% 擬提前贖回“振德轉債”
格隆匯11月10日丨振德醫療(603301.SH)現報66.66元,跌8.02%,最新總市值143億元。振德醫療昨晚發公告稱,董事會會議決定提前贖回“振德轉債”。投資者除規定時限內在二級市場繼續交易或按照14.01元/股的轉股價格轉股外,僅能選擇以100元/張的票面價格加當期應計利息被強制贖回。若被強制贖回,將面臨較大投資損失。據悉,處於轉股期的轉債,如果連續30個交易日中有15日轉股價值超過130%,上市公司可能會選擇強贖。如果沒在強制贖回規定的期限內交易或轉股,持有人則會遭受贖回價與當時的轉債價格差額損失。按照11月9日振德轉債522.62元的收盤價計算,投資者強制贖回最多將虧損近81%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.